Sinon Corporation, a leading player in the biotechnology and pharmaceutical industry, is headquartered in Taiwan (TW). Founded in 1995, the company has established a strong presence in the Asia-Pacific region, focusing on the development and manufacturing of high-quality biopharmaceuticals and medical devices. Sinon is renowned for its innovative core products, including advanced drug delivery systems and diagnostic reagents, which are distinguished by their precision and reliability. Over the years, Sinon has achieved significant milestones, positioning itself as a trusted partner in healthcare solutions. With a commitment to research and development, Sinon Corporation continues to enhance its market position, contributing to advancements in medical technology and patient care.
How does Sinon Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Salt and Mineral Mining industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Sinon Corporation's score of 42 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Sinon Corporation reported significant carbon emissions, totalling approximately 8,796,574,000 kg CO2e for Scope 1, 253,432,000 kg CO2e for Scope 2, and 48,592,607,000 kg CO2e for Scope 3 emissions. This reflects a slight decrease in Scope 1 emissions from 2023, which were about 7,521,574,000 kg CO2e, while Scope 2 emissions increased slightly from 245,548,000 kg CO2e. Scope 3 emissions also saw a minor reduction from 48,855,843,000 kg CO2e in 2023. Over the past few years, Sinon Corporation's emissions have fluctuated, with Scope 1 emissions peaking at approximately 7,952,088,000 kg CO2e in 2022 and Scope 3 emissions reaching a high of about 58,323,393,000 kg CO2e in 2021. The company has not set specific reduction targets or initiatives as part of the Science Based Targets initiative (SBTi) or other climate pledges, indicating a potential area for future commitment. Sinon Corporation's emissions data is not cascaded from any parent organisation, and all reported figures are derived directly from their own disclosures. The company continues to monitor its carbon footprint across all scopes, aiming for transparency in its environmental impact.
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 2,746,820,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 2 | 237,194,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 58,323,393,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
Sinon Corporation's Scope 3 emissions, which decreased by 1% last year and decreased by approximately 17% since 2021, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Use of Sold Products" being the largest emissions source at 75% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Sinon Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
